391 related articles for article (PubMed ID: 31554479)
41. Hepatocellular carcinoma and liver tumors in South African children: a case for increased prevalence.
Moore SW; Millar AJ; Hadley GP; Ionescu G; Kruger M; Poole J; Stones D; Wainwright L; Chitnis M; Wessels G
Cancer; 2004 Aug; 101(3):642-9. PubMed ID: 15274079
[TBL] [Abstract][Full Text] [Related]
42. Clinicopathologic implication of hepatic progenitor cell marker expression in hepatoblastoma.
Yun WJ; Shin E; Lee K; Jung HY; Kim SH; Park YN; Yu E; Jang JJ
Pathol Res Pract; 2013 Sep; 209(9):568-73. PubMed ID: 23920322
[TBL] [Abstract][Full Text] [Related]
43. Effect of Liver Transplant on Long-term Disease-Free Survival in Children With Hepatoblastoma and Hepatocellular Cancer.
Pham TA; Gallo AM; Concepcion W; Esquivel CO; Bonham CA
JAMA Surg; 2015 Dec; 150(12):1150-8. PubMed ID: 26308249
[TBL] [Abstract][Full Text] [Related]
44. The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database.
Haeberle B; Rangaswami A; Krailo M; Czauderna P; Hiyama E; Maibach R; Lopez-Terrada D; Aronson DC; Alaggio R; Ansari M; Malogolowkin MH; Perilongo G; O'Neill AF; Trobaugh-Lotrario AD; Watanabe K; Schmid I; von Schweinitz D; Ranganathan S; Yoshimura K; Hishiki T; Tanaka Y; Piao J; Feng Y; Rinaldi E; Saraceno D; Derosa M; Meyers RL
Pediatr Blood Cancer; 2020 Aug; 67(8):e28350. PubMed ID: 32383794
[TBL] [Abstract][Full Text] [Related]
45. Pediatric liver transplantation for hepatocellular cancer and rare liver malignancies: US multicenter and single-center experience (1981-2015).
Vinayak R; Cruz RJ; Ranganathan S; Mohanka R; Mazariegos G; Soltys K; Bond G; Tadros S; Humar A; Marsh JW; Selby RR; Reyes J; Sun Q; Haberman K; Sindhi R
Liver Transpl; 2017 Dec; 23(12):1577-1588. PubMed ID: 28834194
[TBL] [Abstract][Full Text] [Related]
46. Paediatric hepatoblastoma and hepatocellular carcinoma: retrospective study.
Chan KL; Fan ST; Tam PK; Chiang AK; Chan GC; Ha SY
Hong Kong Med J; 2002 Feb; 8(1):13-7. PubMed ID: 11861987
[TBL] [Abstract][Full Text] [Related]
47. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.
Meyers RL; Rowland JR; Krailo M; Chen Z; Katzenstein HM; Malogolowkin MH
Pediatr Blood Cancer; 2009 Dec; 53(6):1016-22. PubMed ID: 19588519
[TBL] [Abstract][Full Text] [Related]
48. Clear cell hepatocellular carcinoma arising 25 years after the successful treatment of an infantile hepatoblastoma.
Basile J; Caldwell S; Nolan N; Hammerle C
Ann Hepatol; 2010; 9(4):465-7. PubMed ID: 21057168
[TBL] [Abstract][Full Text] [Related]
49. The comparison of grey-scale ultrasonic and clinical features of hepatoblastoma and hepatocellular carcinoma in children: a retrospective study for ten years.
Zhuang H; Peng YL; Chen TW; Jiang Y; Luo Y; Zhang Q; Yang ZG
BMC Gastroenterol; 2011 Jun; 11():78. PubMed ID: 21702993
[TBL] [Abstract][Full Text] [Related]
50. Predictors of survival following liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma: Experience from the Society of Pediatric Liver Transplantation (SPLIT).
Boster JM; Superina R; Mazariegos GV; Tiao GM; Roach JP; Lovell MA; Greffe BS; Yanni G; Leung DH; Elisofon SA; McDiarmid SV; Gupta NA; Lobritto SJ; Lemoine C; Stoll JM; Vitola BE; Daniel JF; Sayed BA; Desai DM; Martin AE; Amin A; Anand R; Anderson SG; Sundaram SS
Am J Transplant; 2022 May; 22(5):1396-1408. PubMed ID: 34990053
[TBL] [Abstract][Full Text] [Related]
51. Current chemotherapeutic approaches for hepatoblastoma.
Watanabe K
Int J Clin Oncol; 2013 Dec; 18(6):955-61. PubMed ID: 24052132
[TBL] [Abstract][Full Text] [Related]
52. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
[TBL] [Abstract][Full Text] [Related]
53. Hepatoblastoma: a clinico-pathologic review.
Pollice L; Zito FA; Troia M
Pathologica; 1992; 84(1089):25-32. PubMed ID: 1323095
[TBL] [Abstract][Full Text] [Related]
54. Tissue microarray immunohistochemical profiles of p53 and pRB in hepatocellular carcinoma and hepatoblastoma.
Azlin AH; Looi LM; Cheah PL
Asian Pac J Cancer Prev; 2014; 15(9):3959-63. PubMed ID: 24935581
[TBL] [Abstract][Full Text] [Related]
55. Fibrolamellar hepatocellular carcinoma in children and adolescents.
Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Qu W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
Cancer; 2003 Apr; 97(8):2006-12. PubMed ID: 12673731
[TBL] [Abstract][Full Text] [Related]
56. Childhood hepatocellular carcinoma: a clinicopathological study of 12 cases with special reference to EpCAM.
Zen Y; Vara R; Portmann B; Hadzic N
Histopathology; 2014 Apr; 64(5):671-82. PubMed ID: 24138022
[TBL] [Abstract][Full Text] [Related]
57. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects.
Buendia MA
Med Pediatr Oncol; 2002 Nov; 39(5):530-5. PubMed ID: 12228912
[TBL] [Abstract][Full Text] [Related]
58. Pediatric Liver Tumors.
Ng K; Mogul DB
Clin Liver Dis; 2018 Nov; 22(4):753-772. PubMed ID: 30266161
[TBL] [Abstract][Full Text] [Related]
59. Liver neoplasia in children.
Hadzic N; Finegold MJ
Clin Liver Dis; 2011 May; 15(2):443-62, vii-x. PubMed ID: 21689623
[TBL] [Abstract][Full Text] [Related]
60. Liver tumours.
Perilongo G; Shafford EA
Eur J Cancer; 1999 Jun; 35(6):953-8; discussion 958-9. PubMed ID: 10533478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
